These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32206949)

  • 41. ASO Author Reflections: The Impact of Circular FAT1 in Esophageal Squamous Cell Carcinoma: Investigation of a Novel Tumor Suppressor.
    Takaki W; Konishi H; Shoda K; Otsuji E
    Ann Surg Oncol; 2022 Dec; 29(Suppl 3):579-580. PubMed ID: 34665360
    [No Abstract]   [Full Text] [Related]  

  • 42. ASO Author Reflections: ypTNM Stage Grouping in the 8th Edition of the AJCC Cancer Staging Manual Refines the Prognostic Prediction for Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy.
    Sudo N; Ichikawa H; Muneoka Y; Hanyu T; Kano Y; Ishikawa T; Hirose Y; Miura K; Shimada Y; Nagahashi M; Sakata J; Kobayashi T; Bamba T; Nakagawa S; Kosugi SI; Wakai T
    Ann Surg Oncol; 2021 Feb; 28(2):661-662. PubMed ID: 33001302
    [No Abstract]   [Full Text] [Related]  

  • 43. ASO Author Reflections: Esophagectomy Versus Nonsurgical Treatment for Resectable Esophageal Cancer.
    Ohkura Y
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):703-704. PubMed ID: 30251022
    [No Abstract]   [Full Text] [Related]  

  • 44. ASO Author Reflections: Perineural Invasion in pN0M0 Esophageal Squamous Cell Carcinoma: Let Pathology Strengthen the Clinical Oncology Practice.
    Guo YN; Su M
    Ann Surg Oncol; 2020 Oct; 27(11):4382-4383. PubMed ID: 32632885
    [No Abstract]   [Full Text] [Related]  

  • 45. ANO9 Regulated Cell Cycle in Human Esophageal Squamous Cell Carcinoma.
    Katsurahara K; Shiozaki A; Kosuga T; Kudou M; Shoda K; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Marunaka Y; Otsuji E
    Ann Surg Oncol; 2020 Sep; 27(9):3218-3230. PubMed ID: 32227267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ASO Author Reflections: The Role of Robot-Assisted Ivor Lewis Esophagectomy for Esophageal Cancer.
    Zhang Y; Li H
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):594-595. PubMed ID: 31025227
    [No Abstract]   [Full Text] [Related]  

  • 47. ASO Author Reflections: Decrease of Albumin and Derived Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy Reflect the Worse Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
    Abe T; Oshikiri T; Goto H; Kato T; Horikawa M; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
    Ann Surg Oncol; 2022 Oct; 29(11):6867-6868. PubMed ID: 35616746
    [No Abstract]   [Full Text] [Related]  

  • 48. ASO Author Reflections: COL8A1 Regulates Esophageal Squamous Carcinoma.
    Hu J; Yan S
    Ann Surg Oncol; 2024 May; 31(5):3033. PubMed ID: 38361091
    [No Abstract]   [Full Text] [Related]  

  • 49. ASO Author Reflection: Use of Endobronchial Ultrasound in the Evaluation of Recurrent Laryngeal Nerve Lymph Nodes in Esophageal Squamous Cell Carcinoma Patients.
    Fu X; Fu J; Zhang X
    Ann Surg Oncol; 2021 Jul; 28(7):3939-3940. PubMed ID: 33913047
    [No Abstract]   [Full Text] [Related]  

  • 50. ASO Author Reflections: Total Lesion Glycolysis Ratio in Positron Emission Tomography and Computed Tomography Images During Neoadjuvant Chemotherapy: Usefulness and Perspectives as an Evaluation Tool for the Effect of Neoadjuvant Treatment on Esophageal Squamous Cell Carcinoma.
    Sonoda A; Yoshida N; Baba H
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):806-807. PubMed ID: 32623607
    [No Abstract]   [Full Text] [Related]  

  • 51. ASO Author Reflections: Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus.
    Kanda M; Koike M; Kodera Y
    Ann Surg Oncol; 2020 Sep; 27(9):3206-3207. PubMed ID: 32246315
    [No Abstract]   [Full Text] [Related]  

  • 52. ASO Author Reflections: Endoscopic Ultrasonography for Determining Clinical T Classification for Esophageal Squamous Cell Carcinoma.
    Yang HX; Yang J
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):956-957. PubMed ID: 30456674
    [No Abstract]   [Full Text] [Related]  

  • 53. Author Reflections: Relationship of Systemic Inflammatory Response Indicators at Recurrence to Long-Term Outcomes in Patients with Recurrent Esophageal Squamous Cell Carcinoma: The Utility of Neutrophil-to-Lymphocyte Ratio.
    Takeuchi M; Hoshino S; Kawakubo H; Matsuda S; Mayanagi S; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
    Ann Surg Oncol; 2021 Jun; 28(6):3009-3010. PubMed ID: 33651215
    [No Abstract]   [Full Text] [Related]  

  • 54. [Esophagectomy for squamous cell carcinoma of the esophagus isolated or associated with head and neck cancer: long-term survival].
    Roullet MH; Wind P; Zinzindohoué F; Laccourreye O; Berger A; Chevallier JM; Bonfils P; Brasnu D; Cugnenc PH
    Ann Chir; 2001 Jul; 126(6):526-34. PubMed ID: 11486535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ASO Author Reflections: Optimized Cutoff Value of Albumin-Bilirubin Score to Predict Prognosis of Patients with Esophageal Squamous Cell Carcinoma After Radical Resection.
    Shinozuka T; Kanda M; Kodera Y
    Ann Surg Oncol; 2022 Aug; 29(8):4897-4898. PubMed ID: 35362842
    [No Abstract]   [Full Text] [Related]  

  • 56. ASO Author Reflections: Cervicothoracoscopic Esophagectomy for Esophageal Cancer.
    Takahashi K; Okamura A; Watanabe M
    Ann Surg Oncol; 2020 May; 27(5):1531-1532. PubMed ID: 32124122
    [No Abstract]   [Full Text] [Related]  

  • 57. Delayed post-oesophagectomy gastric conduit obstruction: two decades after oesophagectomy for oesophageal squamous cell carcinoma.
    Jeswanth J; Harikrishnan S; Chandramohan A; Manickavasagam K; Servarayan Murugesan C
    ANZ J Surg; 2021 Mar; 91(3):E163-E164. PubMed ID: 33017085
    [No Abstract]   [Full Text] [Related]  

  • 58. ASO Author Reflections: Concurrent Selective Lymph Node Radiotherapy and S-1 Plus Cisplatin for Esophageal Squamous Cell Carcinoma.
    Wang X; Liu X; Li B
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):741-742. PubMed ID: 31549314
    [No Abstract]   [Full Text] [Related]  

  • 59. ASO Author Reflections: Body Mass Index and Complications After Esophagectomy.
    Wang P; Li Y; Zhu Z
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):737-738. PubMed ID: 31538288
    [No Abstract]   [Full Text] [Related]  

  • 60. NOX4 overexpression is a poor prognostic factor in patients undergoing curative esophagectomy for esophageal squamous cell carcinoma.
    Chen YH; Lu HI; Lo CM; Hsiao CC; Li SH
    Surgery; 2020 Mar; 167(3):620-627. PubMed ID: 31889545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.